Method to increase the absorption of unsaturated fatty acids by human infants
Abstract
The present invention relates to a method to increase the absorption by a human infant of at least one unsaturated fatty acid, said method comprising the enteral administration to said infant of recombinant human bile-salt-stimulated lipase (rhBSSL). In another aspect the invention also relates to a method to improve the visual and/or cognitive development of a human infant, said method comprising the enteral administration to said infant of rhBSSL. Such methods have particular utility for preterm human infants, particular those in medical need of increasing their absorption of or availability to such unsaturated fatty acids. In further aspects, the invention relates to kits, packaged-pharmaceutical-products, recombinant human bile-salt-stimulated lipase and pharmaceutical compositions, in each case useful for increasing the absorption by a human infant of at least one unsaturated fatty acid, or for increasing the visual and/or cognitive development of a human infant.
Claims
exact text as granted — not AI-modified1 . A method to increase the absorption by a human infant of at least one unsaturated fatty acid, said method comprising the step of enteral administration of recombinant human bile-salt-stimulated lipase to said infant.
Join the waitlist — get patent alerts
Track US2015297683A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.